Skip to content
healthcare.dev
Get a free key

FILSPARI

NDC 68974-200, sparsentan, tablet, film coated, from Travere Therapeutics, Inc..

Product NDC
68974-200
Status
Listed
Labeler
Travere Therapeutics, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216403
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68974-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SPARSENTAN200 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
68974-200-306897402003030 TABLET, FILM COATED in 1 BOTTLE (68974-200-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7354af1-f304-f4d9-e053-2995a90ab219

Use it

Look up 68974-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68974-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68974-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.